HistoSonics

HistoSonics

Private
Plymouth, MinnesotaHealthcare & Life Scienceshttps://www.histosonics.com

Last Round

Series D

10/16/2025

Est. Valuation

$3B

Total Funding Raised

$465.3M

Momentum Score

25 /100

Company Overview

HistoSonics is a medical technology company that offers a groundbreaking non-invasive sonic beam therapy platform for liquefying and destroying targeted tissues at a sub-cellular level with exceptional precision and control.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Precision Medicine, Industrial Robotics, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Usage-Based SaaS, Government Contracts

AI Layer

Non-AI

Keywords

histotripsynon-invasive ablationfocused ultrasoundliver tumor treatmenttumor ablationnon-thermal ablationmechanical ablationmedical devicesonic beam therapyrobotically assisted therapyinterventional oncologyrobotic surgeryimage-guided therapytissue liquefactionmedical capital equipmentkidney tumor treatmentpancreas tumor treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HistoSonics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

HistoSonics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series D10/16/2025
Majority Stake Acquisition8/7/2025
IPO1/27/2025
Series D8/15/2024
VC Round12/13/2022
Series C Extension
6/8/2020

Key People

Founding team and executive leadership

Mike Blue

President And CEO

Executive Team

David Krenn

Chief Financial Officer

Executive Team

HistoSonics Investors

Notable investors and investment history

InvestorRounds
Early Stage PartnersSeries B, Series A
Alpha Wave VenturesSeries D
Amzak HealthSeries D
Yonjin CapitalSeries D, VC Round, Series C Extension
Founders FundSeries D
Hatteras Venture PartnersSeries B, Series A
Bezos ExpeditionsMajority Stake Acquisition, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 4, 2026

    Keynote speaker at DeviceTalks Minnesota on May 4, 2026.

  • Mar 1, 2026

    Edison System, a non-invasive sonic beam therapy, is now commercial-stage.

HistoSonics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HistoSonics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HistoSonics's valuation, stock price, and market status.

Firmographic Details

HeadquartersPlymouth, Minnesota
Employee Range351
Year Founded2009
Last Funding10/16/2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.